Literature DB >> 19853927

Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection.

Jiri Mestecky1, Zina Moldoveanu, Phillip D Smith, Zdenek Hel, Rashada C Alexander.   

Abstract

The male and female genital tracts are protected by a local immune system that displays features distinguishing them from other mucosal sites. In contrast to the intestinal tract, where locally produced IgA is the dominant Ig, secretions of the male and female genital tract contain predominantly IgG of both local and systemic origin. Genital tract tissues also lack mucosal lymphoepithelial inductive sites analogous to intestinal Peyer's patches; consequently, local immunization or infections with sexually transmitted pathogens induce low immune responses. Human immunodeficiency virus 1 (HIV-1) infection must be primarily considered as a mucosal disease with extensive involvement of the systemic immune compartment. Although the majority of infections is acquired through the genital mucosa, a high rate of virus replication and profound CD4(+) T cell depletion occurs in the intestinal mucosa and other mucosal tissues shortly after infection. Evaluation of HIV-specific antibodies in sera and external secretions, including vaginal washes and semen, unexpectedly revealed a selective lack of IgA responses. Moreover, specific antibody-secreting cells in peripheral blood were of the IgG isotype, even in mucosally infected individuals. Whether humoral responses to previously or newly encountered antigens are compromised in HIV-1-infected persons is under current investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853927      PMCID: PMC2802574          DOI: 10.1016/j.jri.2009.07.005

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  39 in total

1.  Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection.

Authors:  R Kaul; F Plummer; M Clerici; M Bomsel; L Lopalco; K Broliden
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

Review 2.  Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.

Authors:  Melissa Pope; Ashley T Haase
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

3.  Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia.

Authors:  L Dorrell; A J Hessell; M Wang; H Whittle; S Sabally; S Rowland-Jones; D R Burton; P W Parren
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

4.  Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.

Authors:  M Raux; L Finkielsztejn; D Salmon-Céron; H Bouchez; J L Excler; E Dulioust; J M Grouin; D Sicard; C Blondeau
Journal:  AIDS Res Hum Retroviruses       Date:  1999-10-10       Impact factor: 2.205

5.  Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

Authors:  Ronald S Veazey; Robin J Shattock; Melissa Pope; J Christian Kirijan; Jennifer Jones; Qinxue Hu; Tom Ketas; Preston A Marx; Per Johan Klasse; Dennis R Burton; John P Moore
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

6.  Progesterone implants enhance SIV vaginal transmission and early virus load.

Authors:  P A Marx; A I Spira; A Gettie; P J Dailey; R S Veazey; A A Lackner; C J Mahoney; C J Miller; L E Claypool; D D Ho; N J Alexander
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

7.  A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

Authors:  Nobuyuki Matoba; Aude Magérus; Brian C Geyer; Yunfang Zhang; Mrinalini Muralidharan; Annette Alfsen; Charles J Arntzen; Morgane Bomsel; Tsafrir S Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

8.  Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.

Authors:  L Bélec; T Dupré; T Prazuck; C Tévi-Bénissan; J M Kanga; O Pathey; X S Lu; J Pillot
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

9.  Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees.

Authors:  Z R Israel; P A Marx
Journal:  J Med Primatol       Date:  1995-02       Impact factor: 0.667

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  37 in total

1.  A novel retinoic acid, catechin hydrate and mustard oil-based emulsion for enhanced cytokine and antibody responses against multiple strains of HIV-1 following mucosal and systemic vaccinations.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

2.  Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques.

Authors:  Kristina Rothaeusler; Zhong-Min Ma; Huma Qureshi; Timothy D Carroll; Tracy Rourke; Michael B McChesney; Christopher J Miller
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

Authors:  Pooja Ralli-Jain; Delia Tifrea; Chunmei Cheng; Sukumar Pal; Luis M de la Maza
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 4.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

Review 5.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?

Authors:  Per Johan Klasse; Rogier W Sanders; Andrea Cerutti; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-20       Impact factor: 2.205

Review 6.  Innate and adaptive anti-HIV immune responses in the female reproductive tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Charles R Wira
Journal:  J Reprod Immunol       Date:  2013-03       Impact factor: 4.054

7.  HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.

Authors:  Genevieve G Fouda; Nicole L Yates; Justin Pollara; Xiaoying Shen; Glenn R Overman; Tatenda Mahlokozera; Andrew B Wilks; Helen H Kang; Jesus F Salazar-Gonzalez; Maria G Salazar; Linda Kalilani; Steve R Meshnick; Beatrice H Hahn; George M Shaw; Rachel V Lovingood; Thomas N Denny; Barton Haynes; Norman L Letvin; Guido Ferrari; David C Montefiori; Georgia D Tomaras; Sallie R Permar
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

8.  Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.

Authors:  Tasha Biesinger; Robert White; Monica T Yu Kimata; Brenda K Wilson; Jonathan S Allan; Jason T Kimata
Journal:  Retrovirology       Date:  2010-10-13       Impact factor: 4.602

9.  Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Authors:  Diego A Vargas-Inchaustegui; Marjorie Robert-Guroff
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

10.  The effects of circumcision on the penis microbiome.

Authors:  Lance B Price; Cindy M Liu; Kristine E Johnson; Maliha Aziz; Matthew K Lau; Jolene Bowers; Jacques Ravel; Paul S Keim; David Serwadda; Maria J Wawer; Ronald H Gray
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.